company FBLG - SteadyBase

steadybase-$ company FBLG

account_id none on file

legal_name FibroBiologics, Inc.

ticker FBLG

cik 1958777

domain fibrobiologics.com

linkedin_company_url https://www.linkedin.com/company/fibrobiologics

entry_point_account_id none on file

name FibroBiologics Inc.

exchange Nasdaq

sector Health Care

irhttps://ir.fibrobiologics.com/

sector index/company/sector/health-care/

calls 0 filings 5 executives 1 family 0

why_nownone on file

callsnone on file

filings

• decreased travel expenses of $0.1 million; and • increased costs associated with maintaining our Nasdaq listing of $0.1 million.

filing / Jul 31, 2026 / receipt

This process, which is commonly referred to as “householding,” potentially means extra convenience for stockholders and cost savings for companies.

filing / Jul 31, 2026 / receipt

In June 2023, the Company entered into a new lease for temporary lab and office space for its research operations. This lease had a term of 12 months and monthly re nt of $ 6,000 and was accounted for as a short-term lease.

filing / Jul 31, 2026 / receipt

During the six months ended June 30, 2026, we have implemented measures to reduce operating expenses including delaying certain research and development project spend while prioritizing near term pipeline projects, limiting finance, legal and administrative costs, and decreasing spend on office space.

filing / Jul 31, 2026 / receipt